cbl-b Inhibits EGF-Receptor-Induced Apoptosis by Enhancing Ubiquitination and Degradation of Activated Receptors

详细信息    查看全文

• 作者：Ettenberg ; Seth A. ; Rubinstein ; Yaffa R. ; Banerjee ; Priya ; Nau ; Marion M. ; Keane ; Maccon M. ; et. al.
• 刊名：Molecular Cell Biology Research Communications
• 出版年：1999
• 出版时间：August, 1999
• 年：1999
• 卷：2
• 期：2
• 页码：111-118
• 全文大小：271 K

文摘

Studies in C. elegans and Drosophila melanogastor suggest that cbl proteins are inhibitors of epidermal growth factor receptor (EGFR) function. Here we describe that overexpression of cbl-b, a homologue of the c-cbl protooncogene, inhibits EGFR-induced apoptosis in MDA-MB-468 breast cancer cells. Overexpression of cbl-b results in a shortened duration of EGFR activation upon EGF stimulation. This is demonstrated by decreased amounts of phosphorylated EGFR as well as by inhibition of multiple downstream signaling pathways. The inhibition of signaling by cbl-b results from increased ubiquitination and degradation of the activated EGFR. The inhibitory effects of cbl-b overexpression on apoptosis and on EGFR signaling are reversed by blocking proteosomal degradation of the EGFR. These data demonstrate that the mechanism by which cbl-b inhibits EGFR-induced apoptosis is by activation-dependent degradation of the EGFR. They imply that this mechanism may be a general one whereby cbl proteins regulate intracellular signaling.